SCHEMBL14720296

SCHEMBL14720296

CC(C)(C)[N+]1(C(=O)O)CC[C@@H](CNC(=O)c2ccc(Br)cc2F)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K1 Q02750 1/20 0.43
TMEM97 Q5BJF2 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
USP30 Q70CQ3 1/20 0.39
DRD2 P14416 3/20 0.38
DRD4 P21917 2/20 0.38
DRD3 P35462 2/20 0.38
CNR2 P34972 1/20 0.38
PPARD Q03181 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
USP5 P45974 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
ADRA2A P08913 2/20 0.36
NPY5R Q15761 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720415 0.90 DRD2 (0.38) MAP2K1DRD2DRD4DRD3RAB9A
SCHEMBL14720417 0.83 HDAC3 (0.41) NPC1RAB9AKMT2AALDH1A1LMNA
SCHEMBL14720555 0.81 FASN (0.37) TMEM97SIGMAR1USP30KMT2ADGAT1
SCHEMBL5630504 0.78 MAP2K1 (0.57) MAP2K1TMEM97SIGMAR1DRD2DRD4
SCHEMBL22227216 0.73 MAP2K1 (0.47) MAP2K1TMEM97SIGMAR1USP30DRD2
SCHEMBL14720615 0.71 DRD2 (0.50) MAP2K1TMEM97SIGMAR1USP30DRD2
SCHEMBL12121083 0.69 CNR2 (0.55) MAP2K1CNR2NPC1RAB9ACHRM4
SCHEMBL3346723 0.68 DGAT1 (0.54) TMEM97SIGMAR1USP30PPARDNPC1
SCHEMBL27766092 0.68 DGAT1 (0.51) MAP2K1TMEM97SIGMAR1USP30PPARD
SCHEMBL26838419 0.68 TMEM97 (0.59) TMEM97SIGMAR1PPARDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013028445-A1 FATTY ACID SYNTHASE INHIBITORS GLAXOSMITHKLINE LLC (US) 2013-02-28 WO disclosed